| ¿µ¹® | radical mastectomy | ÇÑ±Û | ±ÙÄ¡À¯¹æÀýÁ¦¼ú |
|---|---|---|---|
| ¼³¸í | À¯¹æ¾Ï¿¡ °É·ÈÀ» ¶§ À¯¹æÀ» ÀýÁ¦ÇÏ´Â ¼ö¼ú¹æ¹ýÀ¸·Î, ¾Ï¿¡ ÀÌȯµÈ À¯¹æ°ú Å«°¡½¿(pectoralis major), ÀÛÀº°¡½¿±Ù(pectoralis minor)°ú °Üµå¶û ¸²ÇÁÀý µîÀ» ¸ðµÎ ÀýÁ¦ÇÏ´Â ¹æ¹ýÀÌ´Ù. ÀÌ ¹æ¹ýÀ» »ç¿ëÇϸé, Ä¡·áÈ¿°ú¿¡ ºñÇØ ³Ê¹« Áö³ªÄ£ ȯÀÚÀÇ ¼ö¼úÈÄ ÇÕº´ÁõÀ» °¡Á®¿À°Ô µÇ¹Ç·Î ¿äÁòÀº Áß¿ä½Å°æ°ú ÀÛÀº°¡½¿±ÙÀ» »ì¸®´Â º¯Çü±ÙÄ¡À¯¹æÀýÁ¦¼ú(modified radical mastectomy)¸¦ ÁÖ·Î ½ÃÇàÇÑ´Ù. |
||
| ¿µ¹® | toxicity | ÇÑ±Û | µ¶¼º |
|---|---|---|---|
| ¼³¸í | »ýü¿¡ ÀÖ¾î ¹Ù¶÷Á÷ÇÏÁö ¾ÊÀº ¾à¹° ÀÛ¿ëÀ» ¸»ÇÑ´Ù. ¾à¹°À» °ú·®À¸·Î »ç¿ëÇϸé Áßµ¶À» ÀÏÀ¸Å°¸ç, ½ÉÇÑ °æ¿ì¿¡´Â Á×À½¿¡ À̸£´Âµ¥ ÀÌ´Â ¾à¹°ÀÇ ±Þ¼º µ¶¼ºÀÌ´Ù. ¸¸¼º µ¶¼ºÀº ¼Ò·®À» Àå±â°£ ¹Ýº¹ ¼·ÃëÇÏ¿´À» ¶§ÀÇ µ¶¼ºÀÌ´Ù. °£, ÄáÆÏ µî ¿©·¯ Àå±â¿Í Á¶Á÷¿¡ ´ëÇÑ µ¶¼º ¿Ü¿¡, ±âÇüÀ¯¹ß¼º, ¹ß¾Ï¼º µîµµ ¾à¹°µ¶¼ºÀÌ´Ù. ¾à¹°µ¶¼ºÀÇ °¾àÀº ±Þ¼º µ¶¼º°Ë»ç(LD50), ¸¸¼º µ¶¼º°Ë»ç, ±âÇüÀ¯¹ß°Ë»ç, ¹ß¾Ï°Ë»ç, ¹ø½Ä°Ë»ç ±âŸ ¿©·¯ µ¿¹°°Ë»ç¿¡ ÀÇÇØ ÆÇÁ¤µÈ´Ù. |
||
| ¿µ¹® | reaction formation | ÇÑ±Û | ¹Ýµ¿Çü¼º, ¹ÝÀÀÇü¼º |
|---|---|---|---|
| ¼³¸í | ¾ï¾Ðº¸´Ù ´õ Àû±ØÀûÀÎ ¹æ¾î¸ÞÄ¿´ÏÁòÀ̸ç, ¹«ÀǽÄÀûÀÎ »ý°¢, ¼Ò¿ø, Ãæµ¿ÀÌ ³Ê¹«³ªµµ ¹Þ¾Æµé¿©Áú ¼ö ¾ø´Â °ÍÀÏ °æ¿ì¿¡ À̿ʹ Á¤¹Ý´ë ¹æÇâÀÇ °ÍÀ» °Á¶ÇÔÀ¸·Î½á ±×·± ¹«ÀǽÄÀûÀÎ °ÍµéÀÌ ÀǽĵÇÁö ¾Ê°Ô ÇÏ´Â °úÁ¤. ¿¹¸¦ µé¸é °¡Àå °¡ÇÐÀûÀÎ ¼º°ÝÀÇ »ç¶÷ÀÌ »ýÃ¼ÇØºÎ ¹Ý´ë·ÐÀÚ°¡ µÇ´Â °æ¿ì¸¦ µé ¼ö ÀÖ´Ù. À̰ÍÀº ¶Ç °¡½¿ ±íÀÌ Àá°ÜÀÖ´Â µÎ·Á¿òÀÌ ÀǽĵǴ °ÍÀ» ÇÇÇϱâ À§Çؼ µÎ·Á¿òÀÇ ´ë»óÀÌ µÇ´Â Çൿ¿¡ °ñ¸ôÇÏ´Â °æ¿ìµµ Æ÷ÇÔÀÌ µÈ´Ù. ¿¹¸¦ µé¸é, ³²ÀÚ¿¡°Ô »óó¹ÞÁö ¾ÊÀ»±î ÇÏ´Â µÎ·Á¿ò¿¡ °¡µæ Âù ¼Ò³à°¡ ÀÌ °°Àº µÎ·Á¿òÀ» ºÎÁ¤ÇÏ·Á´Â ¼ö´ÜÀ¸·Î ³ÀâÇÑ ¼ºÇàÀ§¿¡ °ñ¸ôÇÏ´Â °æ¿ì°¡ ÀÖ´Ù. ¶Ç ÀüóÀÇ Àڳฦ ¹Ì¿öÇÏ´Â °è¸ð°¡ ¿ÀÈ÷·Á Áö³ªÄ¥ Á¤µµ·Î ±× ¾ÆÀ̸¦ ±Í¿©¿öÇÏ´Â ÀÏ µûÀ§ÀÌ´Ù. |
||
| ECG | Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ = EKG 1. Conducting System Structu... |
|---|---|
| MRF | Markov random field; medical record file; melanocyte-[stimulating hormone]-releasing factor; mesence... |
| RF | radial fiber; radio frequency; receptive field; regurgitant fraction; Reitland-Franklin [unit]; rela... |
| SF | Sabin-Feldman [test]; safety factor; salt-free; scarlet fever; screen film; seminal fluid; serosal f... |
| AFR | aqueous flare response; ascorbic free radical |
| AFR | Ascorbate free radical |
|---|---|
| FR | Free radical |
| OFR | Oxygen free radical |
| FRO | free radical oxidation |
| *OH | of hydroxyl free radical |
| radical, free | In biochemistry, it is a group of atoms bonded together into an entity that is extremely reactive and shortlived. (a free radical is not a political extremist on parole.) (12 Dec 1998) |
|---|---|
| free radical | A chemically active atom or molecular fragment containing a chemical charge due to an excess or deficient number of electrons. Radicals seek to receive or release electrons in order to achieve a more stable configuration, a process that can damage the large molecules within cells. See: Oxidation. (09 Oct 1997) |
| free radical reductase | <enzyme> Catalyses conversion of carbon-centreed lipid radicals into an inactive species by utilizing vitamin e at one end and glutathione at the other Registry number: EC 1.8.4.- (26 Jun 1999) |
| free radical scavengers | Substances that influence the course of a chemical reaction by ready combination with free radicals. Among other effects, this combining activity protects pancreatic islets against damage by cytokines and prevents myocardial and pulmonary perfusion injuries. (12 Dec 1998) |
| acute toxicity | <pharmacology> Illness resulting from a single dose or exposure to a toxic substance. Compare: chronic toxicity. (06 May 1997) |
| chronic toxicity | <pharmacology> Illness caused by repeated or long-term exposure to low doses of a toxic substance. Compare: acute toxicity. (09 Oct 1997) |
| digitalis toxicity | A result of the over-accumulation of digitalis glycosides in the body. Kidney insufficiency can be a contributing factor. Symptoms include nausea, vomiting, visual changes, blurred vision, anorexia and palpitations. Treatment is emergent as life-threatening cardiac arrhythmias are possible with higher blood levels. (27 Sep 1997) |
| digoxin toxicity | A result of the over-accumulation of digitalis glycosides in the body. Kidney insufficiency can be a contributing factor. Symptoms include nausea, vomiting, visual changes, blurred vision, anorexia and palpitations. Treatment is emergent as life-threatening cardiac arrhythmias are possible with higher blood levels. (27 Sep 1997) |
| drug toxicity | The systemic effects of a drug that are related to the overall level of the medication in the bloodstream. Drug toxicity may occur with overdosage of a medication, accumulation of the drug in the body over time or the inability of the patients body to eliminate the drug. (27 Sep 1997) |
| oxygen toxicity | A body disturbance resulting from breathing high partial pressures of oxygen; characterised by visual and hearing abnormalities, unusual fatigue while breathing, muscular twitching, anxiety, confusion, incoordination, and convulsions; although the mechanism for development of the condition is obscure, a disruption of enzymatic activity is likely, perhaps as a result of free radical formation. Synonym: oxygen poisoning. (05 Mar 2000) |
| toxicity | The quality of being poisonous, especially the degree of virulence of a toxic microbe or of a poison. (18 Nov 1997) |
| toxicity test | <investigation> Controlled laboratory test to determine the toxicity of a chemical to an organism in terms of specific chemical concentrations. An acute toxicity test establishes the concentration required to kill a predetermined proportion of test organisms within a relatively short period of time, typically 4 days or less. A chronic toxicity test reveals the effects of a sublethal concentration applied throughout all or part of the life cycle. (12 Jan 1998) |
| toxicity tests | Tests that determine the toxicity of a substance. These include tests of clinical drugs, foods, environmental pollutants, etc. (12 Dec 1998) |
| ep toxicity | A test defined by the federal Environmental Protection Agency to check a substance for the presence of arsenic, barium, cadmium, chromium, lead, mercury, selenium, or silver. 40 CFR 261.24 defines the concentrations constituting hazardous waste and the test procedure. (05 Dec 1998) |
| Abbe theory of image formation | <optics, physics> Abbe's theory is based on the fact that a non-self-luminous particle, which is illuminated by an extraneous source, gives rise to diffracted light rays, in addition to the dioptric pencil. He stated that to form a good microscopical image as many of the diffracted rays as possible should be intercepted by the objective. With closely ruled lines, his theory is easily demonstrated by observing the back lens of the objective, for here the diffracted rays can be observed directly if the aperture diaphragm is closed. It can be shown that, when the illumination is arranged to exclude the diffracted images, resolution is lost. (11 Mar 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|